Helping you navigate challenges
As a trusted partner, we bring experience commercializing therapies across conditions like multiple sclerosis, Alzheimer’s disease, Parkinson’s, migraine, epilepsy, and ALS, supporting clients at every stage with a deep understanding of the unique challenges in neurology. Our strategies address diagnostic uncertainty, variable payer policies, and caregiver burden—ensuring that promising therapies reach the right patients. Whether launching high-cost rare disease treatments or supporting CNS portfolios, we guide brands through an evolving market.
Our Expertise & Our People
Our neurology expertise is grounded in clinical knowledge, access strategy, and execution excellence.
Our team includes former brand leaders, HEOR specialists, pharmacists, and access strategists with deep domain knowledge across neurodegenerative and CNS conditions. We extend this with a network of key opinion leaders (KOLs) and former access decision makers who provide real-time insights into treatment trends and access dynamics. With integrated capabilities and efficient implementation, we support clients across the product life cycle—helping translate complex science into real-world impact.
Our Values In Action
Mental Health Awareness Month: Advancing Access to Long-Acting Medications
Maureen Hennessey, Ph.D. | SVP, Director, Value Transformation Christopher Terrone | VP, Healthcare Insights, Market...
